Global Health Economics and Outcomes Research (HEOR) Market Analysis and Forecast Report 2021-2026 Featuring IQVIA, Medpace, Certara, Syneos Health, McKesson Corp & Optum - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Health Economics and Outcomes Research (HEOR) Market Report and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global health economics and outcomes research (HEOR) industry attained a value of USD 1228 million in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 12.5% to reach USD 2459.4 million by 2026.

The services used by healthcare and pharmaceutical companies to determine the value, cost, and cost-effectiveness of products or processes are referred to as health economics and outcomes research (HEOR).

Observational data, price comparison, and other market indicators assist healthcare and pharmaceutical companies in making better informed strategic decisions for their goods. Health economics and outcomes research (HEOR) assists healthcare decision-makers, such as physicians, governments, payers, health ministries, and patients, in comparing and selecting the best treatment options.

The focus of health economics and outcomes research service providers on providing optimal health outcomes for patients from an affordable perspective will increase its demand over the period, thereby facilitating the overall industry growth. The increasing drug development is driving the demand for the HEOR industry.

The overall market will rise as demand for secure services like clinical and preclinical testing, as well as regulatory affairs expertise grows. The use of healthcare IT and analytic technologies allows these CROs to coordinate across several platforms, which will drive up the need for HEOR services in payer decision-making, boosting the market for health economics and outcomes research (HOER).

Health economics and outcomes research aid clinical development by giving useful information about specific treatments, such as population accessibility and competitor pricing. HEOR services are used to determine the price of a newly produced drug and to revise the prices of existing drugs, thereby boosting the industry's growth.

Competitive Landscape

The report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the key players in the industry.

Some of the major players in the market explored in the report are:

• IQVIA Inc.
• Medpace, Inc.
• Certara, Inc.
• Syneos Health
• McKesson Corporation
• Optum, Inc

Key Topics Covered:

1 Preface

2 Report Coverage - Key Segmentation and Scope

3 Report Description

3.1 Market Definition and Outlook

3.2 Properties and Applications

3.3 Market Analysis

3.4 Key Players

4 Key Assumptions

5 Executive Summary

5.1 Overview

5.2 Key Drivers

5.3 Key Developments

5.4 Competitive Structure

5.5 Key Industrial Trends

6 Snapshot

6.1 Global

6.2 Regional

7 Industry Opportunities and Challenges

8 Global Health Economics and Outcomes Research (HEOR) Market Analysis

8.1 Key Industry Highlights

8.2 Global Health Economics and Outcomes Research (HEOR) Historical Market (2016-2020)

8.3 Global Health Economics and Outcomes Research (HEOR) Market Forecast (2021-2026)

8.4 Global Health Economics and Outcomes Research (HEOR) Market by Drugs

8.4.1 Developing Drugs

8.4.2 Approved Drugs

8.5 Global Health Economics and Outcomes Research (HEOR) Market by Service

8.5.1 Real World Evidence

8.5.2 Payer Evidence

8.5.3 Pricing and Reimbursement

8.5.4 Epidemiology Studies

8.5.5 Market Access

8.6 Global Health Economics and Outcomes Research (HEOR) Market by Offering

8.6.1 Outsourced

8.6.2 In-house

8.7 Global Health Economics and Outcomes Research (HEOR) Market by End Use

8.7.1 Healthcare Providers

8.7.2 Government Organizations

8.7.3 Pharma and Biotech Companies

8.7.4 Healthcare Payers

8.8 Global Health Economics and Outcomes Research (HEOR) Market by Region

9 Regional Analysis

10 Market Dynamics

10.1 SWOT Analysis

10.2 Porter's Five Forces Analysis

10.3 Key Indicators for Demand

10.4 Key Indicators for Price

11 Value Chain Analysis

12 Cost Analysis

13 Procurement Strategy

13.1 Sourcing Model

13.2 Engagement Model

13.3 Pricing Model

14 Billing Rates

15 Competitive Landscape

15.1 Market Structure

15.2 Company Profiles

16 Industry Events and Developments

For more information about this report visit https://www.researchandmarkets.com/r/e8lv20

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900